Endocrine Journal | |
Changes in serum thyroglobulin antibody levels as a dynamic prognostic factor for early-phase recurrence of thyroglobulin antibody-positive papillary thyroid carcinoma after total thyroidectomy | |
Ayako Nakayama1  Tomonori Yabuta2  Akihiro Miya2  Minoru Kihara2  Yasuhiro Ito2  Hiroo Masuoka2  Kaoru Kobayashi2  Mitsuhiro Fukushima2  Osamu Yamada1  Takuya Higashiyama2  Akira Miyauchi2  | |
[1] Department of Head and Neck Surgery, Kuma Hospital, Kobe 650-0011, Japan;Department of Surgery, Kuma Hospital, Kobe 650-0011, Japan | |
关键词: TgAb; Papillary thyroid carcinoma; Prognosis; | |
DOI : 10.1507/endocrj.EJ14-0275 | |
学科分类:内分泌与代谢学 | |
来源: Japan Endocrine Society | |
【 摘 要 】
References(9)Cited-By(4)We demonstrated previously that dynamic prognostic markers such as the thyroglobulin (Tg)-doubling time in thyroglobulin antibody (TgAb)-negative papillary thyroid carcinoma (PTC) and changes in pre- and postoperative TgAb levels in TgAb-positive PTC patients more keenly reflect patients’ prognosis than conventional static prognostic factors.Here we investigated periodic changes in TgAb levels in 513 TgAb-positive PTC patients who underwent total thyroidectomy.The TgAb levels at 1 year after surgery decreased to <50% of the preoperative values in 407 (79%) patients, and the remaining 106 (21%) patients showed no decrease in TgAb.In 426 patients, TgAb was also measured more than 1 year after surgery.Compared with their TgAb levels 1 year after surgery, 59 patients (14%) showed an increase in TgAb levels of >20% during the follow-up.The postoperative Tg levels at 1 year after surgery remained positive in 44 (9%) patients despite their TgAb positivity.To date (median follow-up period 35 months), 12 of the 426 patients (3%) showed PTC recurrence, and 11 of these patients showed either or both a TgAb elevation later than 1 year after surgery and postoperative Tg positivity.Although further studies with longer follow-ups are necessary, we can conclude that changes in postoperative TgAb levels may be usable as a surrogate tumor marker for TgAb-positive PTC patients after total thyroidectomy.
【 授权许可】
Unknown
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO201911300620277ZK.pdf | 642KB | download |